Intravitreal bevacizumab injection for retinopathy of prematurity and pulmonary hypertension

被引：2
|
作者：
Park, Lidia [1 ]
Donohue, Lee [2 ]
Lakshminrusimha, Satyan [2 ]
Sankaran, Deepika [2 ]
机构：
[1] Univ Calif Davis, Dept Pediat, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Dept Pediat, Div Neonatol, Sacramento, CA 95817 USA
来源：
JOURNAL OF PERINATOLOGY | 2023年 / 43卷 / 02期
关键词：
ENDOTHELIAL GROWTH-FACTOR; PATHOGENESIS;
D O I：
10.1038/s41372-022-01489-0
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：236 / 237
页数：2
相关论文
共 50 条
  • [31] Neurodevelopmental outcomes after intravitreal bevacizumab injection in Japanese preterm infants with retinopathy of prematurity
    Fujii, Yuya
    Arima, Mitsuru
    Akiyama, Masato
    Mori, Yujiro
    Fujiwara, Kohta
    Inoue, Hirosuke
    Seki, Eiko
    Nakama, Takahito
    Tsukamoto, Shoko
    Ochiai, Masayuki
    Ohga, Shouichi
    Sonoda, Koh-hei
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [32] Retrolental Hemorrhage in Berger's Space After Intravitreal Bevacizumab Injection for Retinopathy of Prematurity
    Shah, Pooja Rajesh
    Sachan, Anusha
    Chandra, Parijat
    JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 2020, 57 (06) : E71 - E73
  • [33] Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity
    L-O Atchaneeyasakul
    A Trinavarat
    Journal of Perinatology, 2010, 30 : 497 - 499
  • [34] Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity
    Atchaneeyasakul, L-O
    Trinavarat, A.
    JOURNAL OF PERINATOLOGY, 2010, 30 (07) : 497 - 499
  • [35] Refractive outcome of intravitreal bevacizumab injection in comparison to spontaneous regression of retinopathy of prematurity (ROP)
    Razavi, Mohammad Etezad
    Shoeibi, Nasser
    Hassanzadeh, Samira
    Kianmehr, Sedigheh
    Bakhtiari, Elham
    STRABISMUS, 2020, 28 (01) : 49 - 54
  • [36] Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors
    Fatemeh Bazvand
    Hamid Riazi-Esfahani
    Ahmad Mirshahi
    Alireza Khodabande
    Hasan Khojastheh
    Afsar Dastjani Farahani
    Ramak Roohipourmoallai
    Marjan Imani
    Hooshang Faghihi
    Nazanin Ebrahimi Adib
    Mohammadreza Mehrabi Bahar
    International Journal of Retina and Vitreous, 7
  • [37] Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain
    Obata, Shumpei
    Ichiyama, Yusuke
    Matsumoto, Riko
    Kakinoki, Masashi
    Saishin, Yoshitsugu
    Yanagi, Takahide
    Maruo, Yoshihiro
    Ohji, Masahito
    PLOS ONE, 2021, 16 (12):
  • [38] What is the optimal dosage for intravitreal bevacizumab for retinopathy of prematurity?
    Kim, Hoon Dong
    Kim, Seung Hoon
    Cho, In Hwan
    Moon, Chan Hee
    Ohn, Young-Hoon
    Park, Tae Kwann
    ACTA OPHTHALMOLOGICA, 2013, 91 (02) : e154 - e156
  • [39] Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity
    Ceylan, Osman Melih
    Dikci, Seyhan
    Genc, Oguzhan
    Yilmaz, Turgut
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2016, 79 (04) : 279 - 279
  • [40] Intravitreal low-dosage bevacizumab for retinopathy of prematurity
    Harder, Bjoern C.
    von Baltz, Stefan
    Jonas, Jost B.
    Schlichtenbrede, Frank C.
    ACTA OPHTHALMOLOGICA, 2014, 92 (06) : 577 - 581
12345